Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease
Clinical trial NCT07151157 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07151157
- Sponsor
- Ruijin Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-30
- Primary completion
- 2026-04-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.